Search results
UroGen Pharma appoints new Chief Commercial Officer By Investing.com
Investing.com· 6 days ago(NASDAQ: URGN), a biotech company focused on urothelial and specialty cancers, today announced the...
Geron surges after winning first US FDA approval for blood disorder drug
Reuters· 2 days ago, opens new tab surged more than 30% on Friday, a day after the company gained its first approval...
Why Is Mid-Cap Cancer-Focused Replimune Stock Trading Higher On Thursday?
Benzinga· 2 days agoThursday, Replimune Group Inc REPL released topline results from the primary analysis of the IGNYTE clinical trial of RP1 plus nivolumab in anti-PD1 failed melanoma. Bristol-Myers Squibb Co’ ...
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters· 7 days ago, opens new tab multiple myeloma drug Blenrep nearly halved the risk of disease progression or death...
Cytokinetics shares price target cut on strategic funding collaboration By Investing.com
Investing.com· 5 days agoB.Riley has adjusted the stock price target for Cytokinetics (NASDAQ:CYTK), bringing it down to...
Morning Brew: GameStop Tumbles After Earnings Miss, TSMC Reports
Guru Focus· 2 days agoS&P futures vs fair value: +2.00. Nasdaq futures vs fair value: +31.00.The S&P 500 futures are up...